Capgemini SE CGEMY OTC · Technology · France
$26.58 -3.26% -$0.90
Summary
54 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It has raised its dividend 5 years in a row and pays out only 45% of profit.
What to watch
- Revenue grew by only 0.7% a year over the last 3 years.
- Out of every 100 EUR of revenue, only 5.8 EUR is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.0 EUR for 1 EUR of yearly profit. Over the last five years it was 20.6 EUR on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 7.2% a year over 5 years. Over the last 3 years it grew by 0.7% a year. For the next fiscal year analysts expect revenue to grow by 6.0%. Earnings per share fell by 0.2% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 EUR of revenue goes
- Cost of sales 73 EUR
- Sales and administration 17 EUR
- Taxes and other 6.1 EUR
- Net profit 5.8 EUR
Net profit, industry median (Information Technology Services) 5.9 EUR
Out of every 100 EUR of revenue, 5.8 EUR is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 3.01%
- Paid out of profit
- 45%
- Raised in a row
- 5 years
You receive $0.80 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 2
- Sell 0
No analyst has published a price target.
33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.